RecruitingPhase 2 / Phase 3NCT07284472
Safety and Efficacy of EXV-802 and EXV-801 in the Treatment of Agitation in Alzheimer's Disease Dementia
Sponsor: Exciva GmbH
Murrieta, CA · Indianapolis, IN · Flowood, MS · +6 more sites
4 recruiting Phase 2/3 alzheimer's disease studies in the US. What trial phases mean
Sponsor: Exciva GmbH
Murrieta, CA · Indianapolis, IN · Flowood, MS · +6 more sites
Sponsor: Washington University School of Medicine
Birmingham, AL · La Jolla, CA · Los Angeles, CA · +10 more sites
Sponsor: Washington University School of Medicine
Birmingham, AL · La Jolla, CA · Los Angeles, CA · +10 more sites
Sponsor: T3D Therapeutics, Inc.
Durham, NC
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.